Role of transdermal Testosterone gel pretreatment in poor responders on IVF outcome- A prospective randomised controlled trial with active control

Besins Healthcare India Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients from whom < or equal to 5 oocytes were retrieved at hCG trigger in previous failed IVF/ICSI cycle with:
•1.FSH < or equal to 10
•2.Normal TSH, Prolactin, hepatic and renal function
•3.Normal uterine cavity as assessed by Hysteroscopy and 3D USG
•4.None having taken any fertility medication like gonadotropins or clomiphene in the past 3 months.
•5.Patients willing to participate in the trial

•1.Women with known causes of decreased ovarian reserve like endometriosis grade 3 or higher
•2.Women with pre-existing comorbidities like uncontrolled Diabetes, Hypertension and other chronic diseases like Chronic liver or kidney disease
•3.Women with known autoimmune disorders like SLE, Autoimmune hemolytic anemia
•4.Abnormal parental karyotype Abnormal Uterine cavity such as thin endometrium, severe Adenomyosis
•5.Women not willing to participate

发起方

Besins Healthcare India Private Limited